MicroRNA Therapeutics for Cardiac Regeneration

Author(s): Zhiyong Lei, Joost P.G. Sluijter, Alain van Mil

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 15 , Issue 6 , 2015

Become EABM
Become Reviewer
Call for Editor


It is estimated that a typical myocardial infarction results in the loss of approximately one billion functional cardiomyocytes, which are replaced by a non-contractile fibrous scar, eventually leading to heart failure. The currently available surgical, drug, and device-based therapies cannot reverse the loss of functional myocardium, which is the fundamental cause of the problem. As a result of this lack of an available medical solution, heart failure has evolved into a global epidemic. Therefore, the development of regenerative therapeutic strategies to halt the progression of ischemic heart disease to advanced heart failure has become one of the most urgent medical needs of this century. This review first addresses the extremely limited endogenous regenerative capacity of the mammalian heart, and the benefits and limitations of stem cell-based therapies for cardiac repair. Then it discusses the known roles of microRNAs after cardiac injury and the possibility of employing microRNAs to enhance cardiac regeneration.

Keywords: Cardiac progenitor cells, cardiomyocytes, cardiovascular disease, heart failure, microRNA, regeneration, stem cells, transplantation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 22 April, 2015
Page: [441 - 451]
Pages: 11
DOI: 10.2174/1389557515666150324123913
Price: $65

Article Metrics

PDF: 43